- Research paper
- Open access
- CCA4.0 Intern’l License
- Not for the profit
Majdouline1 El Fouhi, Abdellatif2 Benider, Bouchra3 Haddou Rahou, Abdelhalim4 Mesfioui
Majdouline El Fouhi, Abdellatif Benider, Bouchra Haddou Rahou, Abdelhalim Mesfioui. Epidemiological and pathological features of phyllodes tumor of the breast at the university hospital of Casablanca-Morocco. Special Journal of Pathology, Immunology, and Cancer, 2021, 2(1): 1-10
- Phyllodes tumors or cystosarcoma phyllodes are a rare form of breast tumor common in males than females
- Determination of gender based phyllodes tumor types at the university hospital of Casablanca-Morocco
- Breast-conserving surgery is the main treatment and best diagnosed histologically.
Phyllodes tumors are rare lesions of the breast, it occurs exclusively in females. Their management continues to be questioned.
The objective of our study is to determine the various epidemiological characteristics, of Phyllodes tumors of the breast at the university hospital of Casablanca-Morocco
Materials and Methods:
We retrospectively reviewed 10 patients who had histologically confirmed phyllode tumors; collected in 6 years.
All cases occurred in women, histological examination showed 7 cases of benign, 2 of borderline, and 1 of malignant (sarcoma), the mean age at diagnosis was 47,7 years [range 19–75], the mean tumoral size was 15,3 cm [range 8,5–27], 70% of patients presented with right-sided lesions and 1 case of bilateral location, 10% of patients developed metastasis in axillary lymph nodes, the Median delay between the appearance of the tumor and a medical examination was 17,6 months, surgical treatment consisted of an enlarged mastectomy for 60% of the patients. 10% of our cases had adjuvant radiotherapy. The evolution was marked by a local tumor recurrence in one patient during the first 12 months and no death was noticed.
Literature data and our study showed that diagnosis of phyllode tumor is histological, the treatment is exclusively surgical, the distinctive features in our series were: long delay before consulting (17,6 months) which aggravate the prognosis, important tumor size, predominant benign and borderline histological types, it seems urgent to improve health’s education.
Phyllodes tumor, Breast cancer, Morocco.
Biology and health laboratory, Ibn tofail university, Kenitra, Morocco. (firstname.lastname@example.org), 2. Mohammed VI Cancer Treatment Center, Ibn rochd university hospital, Casablanca, Morocco. (email@example.com), 3. Research Department, Higher Institute of Nursing Professions and Technical Health, Rabat, Morocco. (firstname.lastname@example.org), 4. Biology and health laboratory, Ibn tofail university, Kenitra, Morocco. (email@example.com)
Majdouline El fouhi,: PhD student, Biology and health laboratory, Ibn tofailUniversity, Kenitra, Morocco. (firstname.lastname@example.org)
Received September 11, 2021: Accepted: October 9, 2021: Published: November 14, 2021
Distribution and usage license:
This open-access article is distributed by the terms and conditions of the Creative Commons Attribution 4.0 International License seen in this link (http://creativecommons.org/licenses/by/4.0/). You are free to use, distribute, and reproduce this article in any medium, provided you give correct credit to the original author(s) and the source, including the provision of a link to the Creative Commons license website. Pls show any modification’s
The phyllode tumor, a lesion limited to mammary tissue, is rare that account for less than 1% of all breast neoplasms, it is often misdiagnosed as fibroadenomas while imaging test (ultrasound or mammogram), The diagnosis can often be made with a core needle biopsy (Figure A and B), fibroadenomas grow up to 2-3 cm and then stop growing but phyllodes tumors grow continually and sometimes are to 40 cm big, phyllode tumor was first described by Muller in 1838 and its cause remains unclear.
Fibroadenoma versus benign phyllodes, (Figure A and B (1) is a disease almost exclusively of women and occurs most often in the third and fourth decades of life, although there are reports of occurrences in adolescents. Rarely, phyllodes tumors develop in males, usually in those with a condition called gynecomastia.
Epidemiological data suggest that the incidence of phyllodes tumors may be higher in whites in general and in Latina whites and the East (Asians) in particular .
At present time, the exact etiology of phyllodes tumor and its relationship with fibroadenoma are unclear.
Evaluation of any new breast lump includes clinical examination, breast imaging, and needle biopsy, it is often difficult to distinguish benign phyllodes tumor from cellular fibroadenomas, it is frequently necessary to complete excise the lump to get a definitive diagnosis. Wide local excision, with an adequate margin of normal breast tissue, is the preferred initial therapy for phyllodes tumor of the breast .
Some authors separate phyllodes tumors into two subgroups, benign vs malignant , or low vs high-grade , others classify phyllodes tumors into three categories, benign, borderline, and malignant  . From 2003, WHO proposed a classification of three categories: benign, borderline, malignant .
The purpose of this study is to determine the various epidemiological characteristics of phyllodes tumors at the university hospital of Casablanca-Morocco.
Material and Methods
We retrospectively reviewed the record of 10 patients treated in the Oncology Center of the university hospital in Casablanca from January 2012 to December 2018; all the files of patients with histological certainty of phyllodes tumor. Clinical data analyzed included: age, hormonal status, family history of cancer, the circumstance of discovery, diagnosis delay, Tumor size, location, histological classification, lymph nodes metastasis, evolution, treatment, it has been ruled out any file where the histological diagnosis was suspected, an operating sheet was used to collect epidemiological and histological data, and data analysis was performed using SPSS (21).
All 10 patients were female, with a mean age of 47,7 years [range: 19-75]. 60 % of patients were in their periods, 60% of patients were nulliparous, 3 patients had a family cancer history, cancer was discovered through self-examination in 60%, median delay between the appearance of the tumor and a medical examination was 17,6 months [range:2-60].
Tumor size for the series ranged from 8,5 cm to 27 cm, the mean size was 15,3 cm. The majority of tumors were found on the right side (70%) and 1 case had a bilateral tumor. The pathologic diagnosis included 7 benign (figure C), 2 borderline (figure D), and 1 malignant lesion (sarcoma) (figure E). (Table 1)
10% of patients developed regional lymph node metastasis in axillary lymph nodes. The evolution was marked by a local tumor recurrence in one patient during the first 12 months, without any death. Surgical treatment consisted of an enlarged mastectomy for 60% of the patients and adjuvant radiotherapy for 50% of cases.
Table 1: Clinico-pathological characteristics (N=10)
|Family cancer history||-0.3|
|Delay between appearance||17,6 month|
|And medical examination|
|Tumor size||15,3 cm|
|Breast ‘s side||Left||-0.29|
Phyllode tumors are rare breast pathology, according to the literature, the average age ranges between 45 and 60 years [2-3], this matches with our results, the average age in our series was 47.7 years.
The phyllode tumor can occur at any stage of genital life. It often reaches the womanin perimenopause,In our series, the majority of patients (60%) were in their period. The diagnosis delay in our series was 17,6 months, which matches with the previous studies .
Palpable axillary lymphadenopathy can be identified in up to 20% of patients, but metastatic involvement of axillary lymph nodes is rare . In our series; lymph nodes were affected in 10% of cases.
Typically, the phyllode tumor is a nodule of varying volume ranging from 1 to 45 cm [16,17,18], phyllodes tumors can reach enormous proportions; tumors greater than 20 cm have been reported in multiple series . In our study, the tumor measured on average 15,3 cm, it was located on the right side in 70% of cases. Phyllode tumour is bilateral in 32% of cases . In our series, only 2 cases of bilaterality were observed.
Metastases occur most often through blood-borne and are always fatal , they most often sit in the lung and the bones, this matches with our results; one case had lung metastasis.
Local recurrence occurs in approximately 15% of patients with phyllodes tumors and is more frequent after inadequate excision . In our series; 10% of cases had a local recurrence without noticing any death.
The treatment is essentially surgical but it poses the problem of wide exeresis, this must take into account the age of the patient, the size of the tumour compared to the breast, and the histopronostic grade, Cabaret, and al insist on the contribution of the extemporaneous examination to surgical treatment and the need for a wide exeresis .
despite discordant results on the effectiveness of adjuvant radiotherapy seen in several studies . It seems wise to offer it to tumors larger than 5 cm, radiotherapy is indicated in case of a safety margin less than 10 mm during local recurrence or mastectomy , in our series 60% of patients have benefited from an extended mastectomy because of the large tumor size, associated to adjuvant radiotherapy in 10% of cases.
Conclusion of the Phyllodes tumors study
Phyllodes tumors of the breast are rare tumors that present as rapidly growing breast masses and are often misdiagnosed as fibroadenomas. The bears specific clinical characteristics and can be considered as a differential diagnosis for the breast lumps.
The preoperative diagnosis and correct management are crucial in phyllodes tumor because they tend to recur and malignant potential in some of these tumors.
According to our results, efforts should be made to reduce the delay between the appearance of the tumor and medical examination.
WHO: – World Health Organization
Conflict of interest:
The authors declare no conflicts of interest.
Informed consent was obtained from all participants after a detailed explanation of the study.
No funding was received for this study
Conception and study design: Majdouline El fouhi and Abdelhalim Mesfioui and Bouchra Haddou Rahou. Data collection: Majdouline El fouhi . Data analysis and interpretation: Majdouline El fouhi and Bouchra Haddou Rahou . Manuscript drafting: Majdouline El fouhi and Bouchra Haddou Rahou . Manuscript revision: Abdelhalim Mesfioui and Bouchra Haddou Rahou and Abdellatif Benider . All authors approved final version of the manuscript
1- Tan BY, Acs G, Apple SK, et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016 Jan;68(1):5-21
2-Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer. 1993;71 :3020- 3024
3- Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes: Asian variations. Aust N Z J Surg. 1988; 58 :301- 305
4- M. Reinfuss, J. Mituś, K. Duda, A. Stelmach, J. Ryś, K. Smolak. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1996 ; 77(5) : 910-916
5- Chen W.H, Cheng S.P, Tzen C.Y, Yang T.L, Jeng, K.S, Liu C.L, Liu T.P. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. Journal of surgical oncology. 2005 ; 91(3) : 185-194
6- Layfield LJ, Hart J, Neuwirth H. Relation between DNA ploidy and the clinical behavior of phyllodes tumors. Cancer. 1989;64:1486–1489
7- McDivitt RW, Urban JA, Farrow JH. Cystosarcoma phyllodes. Johns Hopkins Med J. 1967;120:33–45
8- Tavassoli FA – 4 edition . Pathology of the Breast. 1999. New York. McGraw-Hill
9- Tavassoli FA, Devilee P. World Health Organization Classification of Tumors, Pathology & Genetics of Tumors of the Breast and Female Genital Organs. International Agency for research on Cancer Press: Lyon. 2003 ; 99–103
10- Moffat CJ, Pinder SE, Dixon AR. Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology 1995;27:205–218
11- Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer. 1978;41:1974–1983
12- Hoover HC, Trestioreanu A, Ketcham AS. Metastatic cystosarcoma phyllode in an adolescent girl : an unusually malignant tumor. Ann Surg. 1975; 181 :279-82
13- Briggs RM, Walter SM. Cystosarcoma phyllodes in adolescent female patients. Am J.Surg. 1983; 146 :712-4
14- L. kanouni, A. Jalil , I. Saadi, H. Sifat, K. Hadadi, H. Errihani, A. Mansouri, N. Benjaafar, F. Ahyoud, A. Souadka, F. Kettani, B.K. El gueddari. Prise en charge des tumeurs phyllodes du sein à l’institut national d’oncologie de Rabat, Morocco. Gynecologieobstetrique & fertilité. 2016 ; 32(4) : 293-301
15- Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer. 1967;20:2090–2099
16- Halverson DJ, Horo-Rubaïna JM. Cystosarcoma phyllodes of the breast. Am J Surg. 1974; 40 :295-301
17- Palmer LM. Treatment options and recurrence potential for cystosarcomaphyllodes. SurgGynecol Obstet. 1990; 170 :193-6.
18- Pietruszka M, Barnes L. Cystosarcomaphyllode: a clinicopathologic analysis of 42cases. Cancer. 1978; 41 :1974-83
19- Dyer NH, Bridger JE, Taylor RS. Cystosarcomaphylloides. Br J Surg. 1966;53:450–455
20- Mangi AA, Smith BL, Gadd MA. Surgical management of phyllodes tumors. Arch Surg. 1999;134:487–492
21- Pandey M, Mathew A, Kattoor J. Malignant phyllodes tumor. Breast J. 2001;7:411–416.
22- Michaud P, Chave B, Lemaire B, Maitre F, Tescher M. Les tumeurs phyllodes du sein. Rev Fr GynecolObstet. 1989; 84 :944-9
23- Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J. 2001;77:428–435.
24- Cabaret V, Delobelle-Deroide A, Vilain MO. Les tumeurs phyllodes. Arch AnatCytolPathol. 1995; 43 :59-72
25- Grabowski J, Salzstein SL, Sadler GR, Blair SL. Malignant phyllodes tumors : a review of 752 cases. Am Surg. 2007 ;73 :967-9
26- Johnstone PA, Pierce LJ, Merino MJ, Yang JC, Epstein AH, Delaney TF. Primary soft tissue sarcomas of the breast : locoregional control with postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1993 ; 27 : 671-5
27- Mangi AA, Smith BL, Gadd MA, Tanabe KK, Ott MJ, Souba WW. Surgical management of phyllodes tumors. Arch Surg. 1999; 134: 487-92
166 total views/reads, 1 views/reads today